Rua Bioscience (NZSE:RUA) Notes Receivable: NZ$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rua Bioscience Notes Receivable?

Rua Bioscience NZSE:RUA +5.56% Notes Receivable is NZ$0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Rua Bioscience's Notes Receivable for the quarter that ended in Dec. 2025 was NZ$0.00 Mil.

Rua Bioscience Notes Receivable Historical Data

* Premium members only.

The historical data trend for Rua Bioscience's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience Notes Receivable Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Rua Bioscience Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NZ$0.00 Mil mean?
Rua Bioscience (NZSE:RUA) has a Notes Receivable of NZ$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Rua Bioscience and its competitors.
Is Rua Bioscience's Notes Receivable too high?
Rua Bioscience's current Notes Receivable is NZ$0.00 Mil.
How does Rua Bioscience's Notes Receivable compare to ZTS and UTHR?
Rua Bioscience's Notes Receivable of NZ$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Rua Bioscience and its competitors. Rua Bioscience's current Notes Receivable is NZ$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Rua Bioscience (NZSE:RUA) has a current Notes Receivable of NZ$0.00 Mil. The current Notes Receivable is NZ$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current Notes Receivable is NZ$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rua Bioscience Business Description

Address 704 Te Araroa Road, RD3, Ruatoria, NZL, 4083
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.